BDTX Black Diamond Therapeutics Inc

Price (delayed)

$2.11

Market cap

$120.91M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.77

Enterprise value

$104.09M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 2

Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery of small molecule, tumor-agnostic therapies. Black Diamond targets undrugged mutations in patients with genetically defined cancers. Black Diamond ...

Highlights
The debt has declined by 21% year-on-year and by 7% since the previous quarter
The revenue has dropped by 100% since the previous quarter and by 100% year-on-year
Black Diamond Therapeutics's gross profit has shrunk by 100% QoQ and by 100% YoY

Key stats

What are the main financial stats of BDTX

BDTX stock price

How has the Black Diamond Therapeutics stock price performed over time
Intraday
0.48%
1 week
-6.22%
1 month
-21.85%
1 year
-16.93%
YTD
-13.17%
QTD
-0.94%

Financial performance

How have Black Diamond Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$53.27M
Net income
-$43.21M
Gross margin
N/A
Net margin
N/A
The revenue has dropped by 100% since the previous quarter and by 100% year-on-year
Black Diamond Therapeutics's gross profit has shrunk by 100% QoQ and by 100% YoY

Price vs fundamentals

How does BDTX's price correlate with its fundamentals

Growth

What is Black Diamond Therapeutics's growth rate over time

Valuation

What is Black Diamond Therapeutics stock price valuation
P/E
N/A
P/B
1.16
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's equity fell by 26% YoY and by 7% QoQ
The P/B is 12% lower than the 5-year quarterly average of 1.3 and 12% lower than the last 4 quarters average of 1.3
The revenue has dropped by 100% since the previous quarter and by 100% year-on-year

Efficiency

How efficient is Black Diamond Therapeutics business performance

Dividends

What is BDTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BDTX.

Financial health

How did Black Diamond Therapeutics financials performed over time
Black Diamond Therapeutics's total assets has decreased by 25% YoY and by 7% from the previous quarter
BDTX's total liabilities is down by 18% YoY and by 7% QoQ
The debt is 86% smaller than the equity
The company's equity fell by 26% YoY and by 7% QoQ
The debt has declined by 21% year-on-year and by 7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.